Artículos por temáticas

Identification of Targets from LRRK2 Rescue Phenotypes

Toh J, Chua LL, Ho P, Sandanaraj E, Tang C, Wang H, Tan EK.

Cells. 2021 Jan 5;10(1):76. doi: 10.3390/cells10010076.

Systemic oxidative stress and cognitive function in Parkinson's disease with different PWMH or DWMH lesions

Chang TC, Chen YC, Huang YC, Lin WC, Lu CH.

BMC Neurol. 2021 Jan 11;21(1):16. doi: 10.1186/s12883-020-02037-z.

Polysomnographic predictors of sleep, motor and cognitive dysfunction progression in Parkinson's disease: a longitudinal study

Bugalho P, Ladeira F, Barbosa R, Marto JP, Borbinha C, da Conceição L, Salavisa M, Saraiva M, Meira B, Fernandes M.

Sleep Med. 2021 Jan;77:205-208. doi: 10.1016/j.sleep.2020.06.020. Epub 2020 Jun 25.

The efficacy of repetitive transcranial magnetic stimulation on emotional processing in apathetic patients with Parkinson's disease: A Placebo-controlled ERP study

Wei W, Yi X, Ruan J, Duan X, Luo H.

J Affect Disord. 2021 Mar 1;282:776-785. doi: 10.1016/j.jad.2020.12.099. Epub 2020 Dec 28.

Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study

Iranzo A, Fairfoul G, Ayudhaya ACN, Serradell M, Gelpi E, Vilaseca I, Sanchez-Valle R, Gaig C, Santamaria J, Tolosa E, Riha RL, Green AJE.

Lancet Neurol. 2021 Mar;20(3):203-212. doi: 10.1016/S1474-4422(20)30449-X.

Down regulation of DNA topoisomerase IIβ exerts neurodegeneration like effect through Rho GTPases in cellular model of Parkinson's disease by Down regulating tyrosine hydroxylase

Yeman KB, Isik S.

Neurol Res. 2021 Jun;43(6):464-473. doi: 10.1080/01616412.2020.1867949. Epub 2021 Jan 5.

Correlations between retinal nerve fiber layer thickness and cognitive progression in Parkinson's disease: A longitudinal study

Zhang JR, Cao YL, Li K, Wang F, Wang YL, Wu JJ, Pei SF, Chen J, Mao CJ, Liu CF.

Parkinsonism Relat Disord. 2021 Jan;82:92-97. doi: 10.1016/j.parkreldis.2020.11.025. Epub 2020 Nov 28.

Articulatory network reorganization in Parkinson's disease as assessed by multimodal MRI and acoustic measures

Klobusiakova P, Mekyska J, Brabenec L, Galaz Z, Zvoncak V, Mucha J, Rapcsak SZ, Rektorova I.

Parkinsonism Relat Disord. 2021 Mar;84:122-128. doi: 10.1016/j.parkreldis.2021.02.012. Epub 2021 Feb 9.

Differentially Expressed Circular RNAs in Peripheral Blood Mononuclear Cells of Patients with Parkinson's Disease

Ravanidis S, Bougea A, Karampatsi D, Papagiannakis N, Maniati M, Stefanis L, Doxakis E.

Mov Disord. 2021 May;36(5):1170-1179. doi: 10.1002/mds.28467. Epub 2021 Jan 12.

Role of gut microbiota in regulating gastrointestinal dysfunction and motor symptoms in a mouse model of Parkinson's disease

Bhattarai Y, Si J, Pu M, Ross OA, McLean PJ, Till L, Moor W, Grover M, Kandimalla KK, Margolis KG, Farrugia G, Kashyap PC.

Gut Microbes. 2021 Jan 1;13(1):1866974. doi: 10.1080/19490976.2020.1866974.

Association of polypharmacy and Parkinson's disease prevalence

Chen Y, Yu Z.

Bratisl Lek Listy. 2021;122(2):158-160. doi: 10.4149/BLL_2021_024.

Benefits under the Sea: The Role of Marine Compounds in Neurodegenerative Disorders

Catanesi M, Caioni G, Castelli V, Benedetti E, d'Angelo M, Cimini A.

Mar Drugs. 2021 Jan 8;19(1):24. doi: 10.3390/md19010024.

Dammarane triterpenes targeting α-synuclein: biological activity and evaluation of binding sites by molecular docking

Cornejo A, Caballero J, Simirgiotis M, Torres V, Sánchez L, Díaz N, Guimaraes M, Hernández M, Areche C, Alfaro S, Caballero L, Melo F.

J Enzyme Inhib Med Chem. 2021 Dec;36(1):154-162. doi: 10.1080/14756366.2020.1851216.

Flexible brain dynamics underpins complex behaviours as observed in Parkinson's disease

Sorrentino P, Rucco R, Baselice F, De Micco R, Tessitore A, Hillebrand A, Mandolesi L, Breakspear M, Gollo LL, Sorrentino G.

Sci Rep. 2021 Feb 18;11(1):4051. doi: 10.1038/s41598-021-83425-4.

The Membrane Interactions of Synuclein: Physiology and Pathology

Runwal G, Edwards RH.

Annu Rev Pathol. 2021 Jan 24;16:465-485. doi: 10.1146/annurev-pathol-031920-092547.